Ambu CEO: Acquisition of company behind shelved product was "the right decision"

Ambu's new CEO, Juan-José Gonzalez, asserts that the million-dollar acquisition of German Invendo Medical and the colonoscope SC210, which is now shelved, was not a waste of money.

Photo: /Ritzau Scanpix/Liselotte Sabroe

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles